Ben Teh
@benwteh.bsky.social
ID physician & Clinician researcher @petermaccc.bsky.social
#TxID #Haem #Vaccination
#TxID #Haem #Vaccination
Reposted by Ben Teh
Challenging CMV Cases in Solid Organ Transplant Recipients
Wednesday 15 October 2025
6.00pm - 7.30pm
Presenters:
Helen Tang (RPAH)
Jenny Li (Alfred)
Becky Lane (ADHB)
To register click asidevents.eventsair.com/cmv-webinars....
Wednesday 15 October 2025
6.00pm - 7.30pm
Presenters:
Helen Tang (RPAH)
Jenny Li (Alfred)
Becky Lane (ADHB)
To register click asidevents.eventsair.com/cmv-webinars....
CMV #2 Webinar
asidevents.eventsair.com
September 8, 2025 at 3:00 AM
Challenging CMV Cases in Solid Organ Transplant Recipients
Wednesday 15 October 2025
6.00pm - 7.30pm
Presenters:
Helen Tang (RPAH)
Jenny Li (Alfred)
Becky Lane (ADHB)
To register click asidevents.eventsair.com/cmv-webinars....
Wednesday 15 October 2025
6.00pm - 7.30pm
Presenters:
Helen Tang (RPAH)
Jenny Li (Alfred)
Becky Lane (ADHB)
To register click asidevents.eventsair.com/cmv-webinars....
Reposted by Ben Teh
Paper 2-Innovation in active and passive immunisation of people who are immunocompromised: a call to action
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Innovation in active and passive immunisation of people who are immunocompromised: a call to action
The proportion of the population with immunocompromising conditions, who are at increased
risk for complications from infectious diseases, continues to grow. Concurrently,
outbreaks due to known and e...
www.thelancet.com
August 12, 2025 at 10:28 AM
Paper 2-Innovation in active and passive immunisation of people who are immunocompromised: a call to action
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Great work by @victoriahall.bsky.social @ncicancer.bsky.social
July 4, 2025 at 8:37 AM
Great work by @victoriahall.bsky.social @ncicancer.bsky.social
I am sure he is too humble to mention his work which was one of the top papers of 2024 for me!
Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy
Cytomegalovirus (CMV) reactivation occurred in 27% of CMV-seropositive chimeric antigen receptor–modified T-cell immunotherapy (CARTx) recipients within 12
academic.oup.com
April 13, 2025 at 3:51 PM
I am sure he is too humble to mention his work which was one of the top papers of 2024 for me!
It was a fantastic overview of the field and the need for more research!
April 5, 2025 at 5:35 AM
It was a fantastic overview of the field and the need for more research!
Fantastic effort Tori!
January 16, 2025 at 11:37 PM
Fantastic effort Tori!
Thanks Steve - looking forward to working with you and the team!
January 1, 2025 at 12:24 PM
Thanks Steve - looking forward to working with you and the team!
Delighted to be part of the team and looking forward to advancing haem
Onc/TxID research!
Onc/TxID research!
January 1, 2025 at 12:23 PM
Delighted to be part of the team and looking forward to advancing haem
Onc/TxID research!
Onc/TxID research!